Edition:
United Kingdom

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.32USD
24 Sep 2018
Change (% chg)

$-0.03 (-0.56%)
Prev Close
$5.35
Open
$5.33
Day's High
$5.33
Day's Low
$5.22
Volume
17,472
Avg. Vol
121,370
52-wk High
$9.69
52-wk Low
$4.44

Chart for

About

Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low... (more)

Overall

Beta: --
Market Cap(Mil.): $276.04
Shares Outstanding(Mil.): 44.31
Dividend: --
Yield (%): --

Financials

  PIRS.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.71 -- --
ROI: -55.96 1.79 14.61
ROE: -132.26 3.28 16.33

BRIEF-Pieris Pharmaceuticals Reports Q1 Loss Per Share $0.17

* PIERIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

10 May 2018

Earnings vs. Estimates